GPER: a novel target in treatment of estrogen-related diseases
Online published: 2013-03-07
Supported by
National Natural Science Foundation of China, 81102890, 30925045;Foundation of the Ministry of Education of China, NCET-10-0967
G protein-coupled estrogen receptor 1 (GPER) is a novel receptor, which belongs to the family of G protein-coupled receptors, to many of the rapid biological responses to estrogen. Different from the two classical nuclear estrogen receptors, ERα and ERβ, GPER modulates both rapid non-genomic reaction and genomic transcriptional events of estrogen. In this regard, GPER may be considered as a valuable target toward novel therapeutic strategy for many estrogen-related diseases. The intrinsic appearance of GPER, including structure, subcellular localization, ligands, signal transduction pathway and relationship with diseases is reviewed in this paper.
Key words: G protein-coupled estrogen receptor 1; gene expression; cancer
WANG Jie, Haji Akber AISA, MA Hai-rong, et al . GPER: a novel target in treatment of estrogen-related diseases[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2013 , 33(2) : 225 . DOI: 10.3969/j.issn.1674-8115.2013.02.020
/
〈 |
|
〉 |